Epitranscriptomic modifications in mesenchymal stem cell differentiation: advances, mechanistic insights, and beyond

J Zheng, Y Lu, Y Lin, S Si, B Guo, X Zhao… - Cell Death & …, 2024 - nature.com
RNA modifications, known as the “epitranscriptome”, represent a key layer of regulation that
influences a wide array of biological processes in mesenchymal stem cells (MSCs). These …

[HTML][HTML] RNA modification: mechanisms and therapeutic targets

L Qiu, Q Jing, Y Li, J Han - Molecular Biomedicine, 2023 - Springer
RNA modifications are dynamic and reversible chemical modifications on substrate RNA
that are regulated by specific modifying enzymes. They play important roles in the regulation …

N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) …

X Zheng, Q Wang, Y Zhou, D Zhang… - Cancer …, 2022 - Wiley Online Library
Abstract Background N‐acetyltransferase 10 (NAT10) is the only enzyme known to mediate
the N4‐acetylcytidine (ac4C) modification of mRNA and is crucial for mRNA stability and …

[HTML][HTML] Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA

C Jin, T Wang, D Zhang, P Yang, C Zhang… - Journal of Experimental …, 2022 - Springer
Abstract Background N4-acetylcytidine (ac4C) as a significant RNA modification has been
reported to maintain the stability of mRNA and to regulate the translation process. However …

N4‐Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF‐1α Positive Feedback Loop

Q Yang, X Lei, J He, Y Peng, Y Zhang, R Ling… - Advanced …, 2023 - Wiley Online Library
Anti‐angiogenic therapy has long been considered a promising strategy for solid cancers.
Intrinsic resistance to hypoxia is a major cause for the failure of anti‐angiogenic therapy, but …

NAT10: an RNA cytidine transferase regulates fatty acid metabolism in cancer cells

MH Dalhat, MRS Mohammed… - Clinical and …, 2022 - Wiley Online Library
Background N‐4 cytidine acetylation (ac4C) is an epitranscriptomics modification catalyzed
by N‐acetyltransferase 10 (NAT10); important for cellular mRNA stability, rRNA biogenesis …

Delivery of m7G methylated Runx2 mRNA by bone-targeted lipid nanoparticle promotes osteoblastic bone formation in senile osteoporosis

J Liu, Y Zhang, Y Wu, G Li, N Ji, R Han, H Tang, X Liu… - Nano Today, 2024 - Elsevier
The loss of bone and destruction of bone microstructure due to aging in senile osteoporosis
(SOP) significantly impair the health and quality of life of the elderly. The pathogenesis of …

Emerging roles of RNA ac4C modification and NAT10 in mammalian development and human diseases

Y Zhang, Y Lei, Y Dong, S Chen, S Sun, F Zhou… - Pharmacology & …, 2023 - Elsevier
RNA ac4C modification is a novel and rare chemical modification observed in mRNA.
Traditional biochemical studies had primarily associated ac4C modification with tRNA and …

[HTML][HTML] RNA modification in cardiovascular disease: implications for therapeutic interventions

C Wang, X Hou, Q Guan, H Zhou, L Zhou… - … and Targeted Therapy, 2023 - nature.com
Cardiovascular disease (CVD) is the leading cause of death in the world, with a high
incidence and a youth-oriented tendency. RNA modification is ubiquitous and indispensable …

Emerging role of RNA acetylation modification ac4C in diseases: current advances and future challenges

J Luo, J Cao, C Chen, H Xie - Biochemical Pharmacology, 2023 - Elsevier
The oldest known highly conserved modification of RNA, N4-acetylcytidine, is widely
distributed from archaea to eukaryotes and acts as a posttranscriptional chemical …